Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

McKesson to acquire Precision Medicine Group for $2.25B

PUBLIC · MCKAug 25, 2026•about 3 hours ago

Acquiring Company

McKesson Corporation

Acquired Company

Precision Medicine Group

IrvingBethesdaBiotechnologyHealth CarePharmaceuticalBiotechnologyHealth Care

Description

McKesson Corporation has signed a definitive agreement to acquire Precision Medicine Group, LLC for about $2.25 billion. After the deal closes, Precision Medicine Group will be integrated into McKesson's Oncology & Multispecialty segment. This acquisition is aimed at bolstering McKesson's capabilities in clinical research and biopharma services.

Company Information

Company

McKesson Corporation

Location

Irving, Texas, United States

About

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable.

Don't miss McKesson Corporation's next move

Get an email the moment McKesson Corporation makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Shivanku
Senior decision-maker at this company
••••••••@••••••••

See Shivanku's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for McKesson Corporation's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Precision Medicine Group?

Precision Medicine Group was acquired by McKesson Corporation, based in Irving. The deal was reported on August 25, 2026. McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson Corporation is publicly traded (MCK) and operates in Biotechnology.

When did McKesson Corporation acquire Precision Medicine Group?

McKesson Corporation's acquisition of Precision Medicine Group was reported on August 25, 2026. McKesson Corporation has signed a definitive agreement to acquire Precision Medicine Group, LLC for about $2.25 billion. After the deal closes, Precision Medicine Group will be integrated into McKesson's Oncology & Multispecialty segment. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Precision Medicine Group do?

Precision Medicine Group is a leading next-generation provider of drug development and commercialization services. The company supports life science organizations from molecule to market by delivering innovative, best-in-class services. It is privately held, operating in Biotechnology, and is based in Bethesda.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.